Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer

Journal of the American College of Surgeons

Volumn 220, Issue 3, 2015, Pages 271-280

  Simpson, Amber L ^a,b   Leal, Julie N ^a   Pugalenthi, Amudhan ^a   Allen, Peter J ^a   Dematteo, Ronald P ^a   Fong, Yuman ^a   Gönen, Mithat ^a   Jarnagin, William R ^a   Kingham, T Peter ^a   Miga, Michael I ^b   Shia, Jinru ^a   Weiser, Martin R ^a   D'Angelica, Michael I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRINOTECAN;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CHOLECYSTECTOMY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SPLEEN VOLUME; STEATOSIS; THROMBOCYTE COUNT; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; CASE CONTROL STUDY; CHEMICALLY INDUCED; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPLICATION; EVALUATION STUDY; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; SINGLE BLIND PROCEDURE; SPLENOMEGALY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 84923223877     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2014.12.008     Document Type: Conference Paper

References (38)

1. E.K. Abdalla, R. Adam, and A.J. Bilchik Improving resectability of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol 13 2006 1271 1280
2. H. Bismuth, R. Adam, and F. Levi Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 1996 509 520 discussion 520-522
3. R. Parks, M. Gonen, and N. Kemeny Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents J Am Coll Surg 204 2007 753 761 discussion 761-763
4. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
5. G. Portier, D. Elias, and O. Bouche Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 2006 4976 4982
6. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
7. J.M. Cleary, K.T. Tanabe, G.Y. Lauwers, and A.X. Zhu Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver Oncologist 14 2009 1095 1105
8. M. Karoui, C. Penna, and M. Amin-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7
9. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072
10. P.S. Wolf, J.O. Park, and F. Bao Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience J Am Coll Surg 216 2013 41 49
11. O. Soubrane, A. Brouquet, and S. Zalinski Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome Ann Surg 251 2010 454 460
12. J.H. Slade, M.L. Alattar, and D.R. Fogelman Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury Clin Colorectal Cancer 8 2009 225 230
13. R. Angitapalli, A.M. Litwin, and P.R. Kumar Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer Oncology 76 2009 363 368
14. L. Rubbia-Brandt, V. Audard, and P. Sartoretti Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 2004 460 466
15. W.R. Jarnagin, M. Gonen, and Y. Fong Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade Ann Surg 236 2002 397 406 discussion 407
16. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
17. R.C. Martin 2nd, D.P. Jaques, M.F. Brennan, and M. Karpeh Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg 194 2002 568 577
18. R. Miller, and D. Siegmund Maximally selected chi square statistics Biometrics 38 1982 1011 1016
19. M.G. House, H. Ito, and M. Gonen Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution J Am Coll Surg 210 2010 744 752 752-755
20. J.S. Tomlinson, W.R. Jarnagin, and R.P. DeMatteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580
21. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318 discussion 318-321
22. M.J. Overman, D.M. Maru, and C. Charnsangavej Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury J Clin Oncol 28 2010 2549 2555
23. M. Katayama, H. Nakano, and S. Kishi A splenic volume increase due to preoperative chemotherapy may impair the long-term outcome after hepatectomy in patients with initially non-optimally resectable colorectal cancer liver metastases Hepatogastroenterology 60 2013 1420 1425
24. J. Kaneko, Y. Sugawara, Y. Matsui, and M. Makuuchi Spleen size of live donors for liver transplantation Surg Radiol Anat 30 2008 515 518
25. J. Kaneko, Y. Sugawara, and Y. Matsui Normal splenic volume in adults by computed tomography Hepatogastroenterology 49 2002 1726 1727
26. A. Harris, T. Kamishima, and H.Y. Hao Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters Eur J Radiol 75 2010 e97 e101
27. M.A. Zago, M.S. Figueiredo, D.T. Covas, and C. Bottura Aspects of splenic hypofunction in old age Klin Wochenschr 63 1985 590 592
28. P. Prassopoulos, M. Daskalogiannaki, and M. Raissaki Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus Eur Radiol 7 1997 246 248
29. R.S. Breiman, J.W. Beck, and M. Korobkin Volume determinations using computed-tomography Am J Roentgenol 138 1982 329 333
30. A.M. Alyassin, J.L. Lancaster, J.H. Downs 3rd, and P.T. Fox Evaluation of new algorithms for the interactive measurement of surface area and volume Med Phys 21 1994 741 752
31. L. Hermoye, I. Laamari-Azjal, and Z. Cao Liver segmentation in living liver transplant donors: comparison of semiautomatic and manual methods Radiology 234 2005 171 178
32. A.L. Simpson, D.A. Geller, and A.W. Hemming Liver planning software accurately predicts postoperative liver volume and measures early regeneration J Am Coll Surg 219 2014 199 207
33. H. Nakano, E. Oussoultzoglou, and E. Rosso Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
34. H. Ando, M. Nagino, and T. Arai Changes in splenic volume during liver regeneration World J Surg 28 2004 977 981
35. K.E. Jacobs, B.C. Visser, and G. Gayer Changes in spleen volume after resection of hepatic colorectal metastases Clin Radiol 67 2012 982 987
36. G. Petrovai, S. Truant, and C. Langlois Mechanisms of splenic hypertrophy following hepatic resection HPB (Oxford) 15 2013 919 927
37. A.C. Charters, D.D. Oakes, and J.P. Froehlich Effect of hepatectomy on mitotic activity in the rat spleen J Surg Res 29 1980 331 337
38. R.J. Holdsworth Regeneration of the spleen and splenic autotransplantation Br J Surg 78 1991 270 278